Literature DB >> 25521330

ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres.

Ulf D Kahlert1,2, Abigail K Suwala2, Eric H Raabe1, Florian A Siebzehnrubl3, Maria J Suarez1, Brent A Orr4, Eli E Bar5, Jaroslaw Maciaczyk2, Charles G Eberhart1.   

Abstract

Diffuse spread through brain parenchyma and the presence of hypoxic foci rimmed by neoplastic cells are two cardinal features of glioblastoma, and low oxygen is thought to drive movement of malignant gliomas in the core of the lesions. Transcription factors associated with epithelial-to-mesenchymal transition (EMT) have been linked to this invasion, and we found that hypoxia increased in vitro invasion up to fourfold in glioblastoma neurosphere lines and induced the expression of ZEB1. Immunohistochemical assessment of 295 surgical specimens consisting of various types of pediatric and adult brain cancers showed that ZEB1 expression was significantly higher in infiltrative lesions than less invasive tumors such as pilocytic astrocytoma and ependymoma. ZEB1 protein was also present in human fetal periventricular stem and progenitor cells and ZEB1 inhibition impaired migration of in vitro propagated human neural stem cells. The induction of ZEB1 protein in hypoxic glioblastoma neurospheres could be partially blocked by the HIF1alpha inhibitor digoxin. Targeting ZEB1 blocked hypoxia-augmented invasion of glioblastoma cells in addition to slowing them in normoxia. These data support the role for ZEB1 in invasive and high-grade brain tumors and suggest its key role in promoting invasion in the hypoxic tumor core as well as in the periphery.
© 2014 International Society of Neuropathology.

Entities:  

Keywords:  EMT; ZEB1; glioma; hypoxia; neural stem cell

Mesh:

Substances:

Year:  2015        PMID: 25521330      PMCID: PMC4470885          DOI: 10.1111/bpa.12240

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  65 in total

1.  Developmental and functional evidence of a role for Zfhep in neural cell development.

Authors:  G Yen; A Croci; A Dowling; S Zhang; R T Zoeller; D S Darling
Journal:  Brain Res Mol Brain Res       Date:  2001-11-30

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

3.  The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells.

Authors:  Simone Brabletz; Karolina Bajdak; Simone Meidhof; Ulrike Burk; Gabriele Niedermann; Elke Firat; Ulrich Wellner; Arno Dimmler; Gerhard Faller; Jörg Schubert; Thomas Brabletz
Journal:  EMBO J       Date:  2011-01-11       Impact factor: 11.598

4.  The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma.

Authors:  E Sánchez-Tilló; L Fanlo; L Siles; S Montes-Moreno; A Moros; G Chiva-Blanch; R Estruch; A Martinez; D Colomer; B Győrffy; G Roué; A Postigo
Journal:  Cell Death Differ       Date:  2013-09-06       Impact factor: 15.828

5.  Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma.

Authors:  Roshan Mahabir; Mishie Tanino; Aiman Elmansuri; Lei Wang; Taichi Kimura; Tamio Itoh; Yusuke Ohba; Hiroshi Nishihara; Hiroki Shirato; Masumi Tsuda; Shinya Tanaka
Journal:  Neuro Oncol       Date:  2013-12-18       Impact factor: 12.300

6.  Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.

Authors:  Balaji Krishnamachary; Shannon Berg-Dixon; Brian Kelly; Faton Agani; David Feldser; Gloria Ferreira; Narayan Iyer; Jessica LaRusch; Brian Pak; Panthea Taghavi; Gregg L Semenza
Journal:  Cancer Res       Date:  2003-03-01       Impact factor: 12.701

7.  Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.

Authors:  Selma Pennacchietti; Paolo Michieli; Maria Galluzzo; Massimiliano Mazzone; Silvia Giordano; Paolo M Comoglio
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

Review 8.  Clinical neurotransplantation protocol for Huntington's and Parkinson's disease.

Authors:  William Omar Contreras Lopez; Guido Nikkhah; Ulf D Kahlert; Donata Maciaczyk; Tomasz Bogiel; Sven Moellers; Elisabeth Schültke; Máté Döbrössy; Jaroslaw Maciaczyk
Journal:  Restor Neurol Neurosci       Date:  2013       Impact factor: 2.406

9.  LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program.

Authors:  Xing-gang Mao; Marianne Hütt-Cabezas; Brent A Orr; Melanie Weingart; Isabella Taylor; Anand K D Rajan; Yazmin Odia; Ulf Kahlert; Jarek Maciaczyk; Guido Nikkhah; Charles G Eberhart; Eric H Raabe
Journal:  Oncotarget       Date:  2013-07

10.  Snail depletes the tumorigenic potential of glioblastoma.

Authors:  K Savary; D Caglayan; L Caja; K Tzavlaki; S Bin Nayeem; T Bergström; Y Jiang; L Uhrbom; K Forsberg-Nilsson; B Westermark; C-H Heldin; M Ferletta; A Moustakas
Journal:  Oncogene       Date:  2013-03-25       Impact factor: 9.867

View more
  41 in total

1.  A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity.

Authors:  Jaroslaw Maciaczyk; Ulf D Kahlert; Katharina Koch; Rudolf Hartmann; Julia Tsiampali; Constanze Uhlmann; Ann-Christin Nickel; Xiaoling He; Marcel A Kamp; Michael Sabel; Roger A Barker; Hans-Jakob Steiger; Daniel Hänggi; Dieter Willbold
Journal:  Cell Death Discov       Date:  2020-04-16

2.  ZEB1 expression in Chinese lower-grade gliomas.

Authors:  Xiangyan Huang; Harrison X Bai; Li Yang
Journal:  J Neurooncol       Date:  2017-04-18       Impact factor: 4.130

3.  Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells.

Authors:  Raffaella Spina; Dillon M Voss; Laura Asnaghi; Andrew Sloan; Eli E Bar
Journal:  J Vis Exp       Date:  2018-01-10       Impact factor: 1.355

4.  Use of cardiac glycosides and risk of glioma.

Authors:  Corinna Seliger; Christoph R Meier; Susan S Jick; Martin Uhl; Ulrich Bogdahn; Peter Hau; M F Leitzmann
Journal:  J Neurooncol       Date:  2015-12-31       Impact factor: 4.130

5.  INSM1 Expression Is Frequent in Primary Central Nervous System Neoplasms but Not in the Adult Brain Parenchyma.

Authors:  Heather M Ames; Lisa M Rooper; John J Laterra; Charles G Eberhart; Fausto J Rodriguez
Journal:  J Neuropathol Exp Neurol       Date:  2018-05-01       Impact factor: 3.685

Review 6.  Migratory potential of transplanted glial progenitors as critical factor for successful translation of glia replacement therapy: The gap between mice and men.

Authors:  Rohit K Srivastava; Jeff W M Bulte; Piotr Walczak; Miroslaw Janowski
Journal:  Glia       Date:  2017-12-20       Impact factor: 7.452

Review 7.  The Unexpected Roles of Aurora A Kinase in Gliobastoma Recurrences.

Authors:  Estelle Willems; Arnaud Lombard; Matthias Dedobbeleer; Nicolas Goffart; Bernard Rogister
Journal:  Target Oncol       Date:  2017-02       Impact factor: 4.493

8.  Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion.

Authors:  Pedro Rosmaninho; Susanne Mükusch; Valerio Piscopo; Vera Teixeira; Alexandre Asf Raposo; Rolf Warta; Romina Bennewitz; Yeman Tang; Christel Herold-Mende; Stefano Stifani; Stefan Momma; Diogo S Castro
Journal:  EMBO J       Date:  2018-06-14       Impact factor: 11.598

9.  ZEB1 expression is increased in IDH1-mutant lower-grade gliomas.

Authors:  Cody L Nesvick; Chao Zhang; Nancy A Edwards; Blake K Montgomery; Michaela Lee; Chunzhang Yang; Herui Wang; Dongwang Zhu; John D Heiss; Marsha J Merrill; Abhik Ray-Chaudhury; Zhengping Zhuang
Journal:  J Neurooncol       Date:  2016-08-27       Impact factor: 4.130

10.  Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells.

Authors:  Ulf D Kahlert; Abigail K Suwala; Katharina Koch; Manabu Natsumeda; Brent A Orr; Masanori Hayashi; Jarek Maciaczyk; Charles G Eberhart
Journal:  J Neuropathol Exp Neurol       Date:  2015-09       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.